AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work together with proprietary research data and computing infrastructure in a way that’s actually useful for scientists. That is exactly the problem Databricks and Nvidia are […] The post Genesis Workbench Launched by Databricks and Nvidia appeared first on HPCwire .
The increasing sophistication of AI models for scientific discovery necessitates better tooling to integrate these models with proprietary data and existing infrastructure.
This development addresses a critical bottleneck in AI adoption for research, potentially accelerating drug discovery and other scientific advancements by making AI more accessible and practical for scientists.
The launch of Genesis Workbench provides a dedicated platform to streamline the integration of advanced AI with real-world scientific research data and computing environments.
- · Databricks
- · Nvidia
- · Pharmaceutical R&D
- · Biotech companies
- · Companies relying on fragmented AI/data workflows
Scientific researchers gain a more efficient platform for AI-driven discovery.
Reduced time and cost for developing new drugs and therapies could lead to more rapid medical advancements.
Increased competition and innovation in the life sciences sector, driven by easier access to powerful AI tools.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at HPCwire